CLINICAL SUPPLY MANAGEMENT ARTICLES
How Early Signals Prevent Risk In Clinical Trial Supply Chains
Small shifts in forecasts, RTSM behavior, and inventory can reveal future supply risks. Learn how early signals help clinical teams prevent disruptions before they escalate.
CLINICAL SUPPLY MANAGEMENT RESOURCES
-
Since the FDA is now encouraging creativity in trial designs, it is important for all stakeholders to adapt processes to follow the science and ultimately bring medicines to patients, faster. This white paper addresses the complexities that come with these trial designs, and how randomization and trial supply management (RTSM) solutions are critical to run flexible, robust, and quality-driven trials.
-
Champion the rare‑disease community by advancing development models built on precision, continuity and global coordination that ensure every dose reaches the patients who need it most.
-
Explore how Interactive Response Technologies (IRTs) built around microservices models can provide faster initial builds, more rapid change management, and improved built-in test automation.
-
Flexible solutions, like demand-led supply and direct-to-patient distribution, are helping sponsors address the growing list of challenges presented by today’s increasingly complex studies.
-
Interactive Response Technology (IRT) can transform site operations by replacing error-prone manual processes with real-time, automated systems that relieve some of the burden on trial sites.
-
As clinical trials grow in complexity, discover how adopting adaptive, unified RTSM technology can help to reduce costs and maintain accurate, real-time study data.
-
How to incorporate flexibility in planning to overcome potential challenges, the value of having a contingency plan, and how a risk-based approach can determine where a contingency plan is needed.